Navigation Links
Merge Technologies' net loss doubles to $10.1M

West Allis, Wis. - Merge Technologies reported a net loss of $10.1 million, or $0.30 per share, in the first quarter of 2007, more than double the net loss of $4.9 million, or $0.15 per share, in the first quarter of 2006.

While the first quarter loss was well below the $27.0 million, or $0.80 per share net loss reported in the fourth quarter of 2......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/10/07


Page: 1

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Merge unveils next-generation imaging-informatics product
3. Merge unveils updated medical imaging software
4. Merge Healthcare suffers $258M loss in `06
5. Merge Healthcare unveils diagnostic mammography tool
6. Merge Healthcare promotes Bowers to president
7. Merge Healthcare hires new VP of finance
8. Merge offshoring jobs to "more cost-effective" workforce
9. Merge Healthcare reports $10.8M net loss in Q3
10. Merge eMed releases software upgrade
11. NASDAQ will continue to list Merge
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... , January 20, 2017 ... cancer is one of leading causes of death worldwide. ... Although the number of cancer related deaths increased gradually ... Rising in incidence rate of various cancers continues to ... a research report by Global Market Insights, Inc. cancer ...
(Date:1/19/2017)... /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, ... platform, today announced that it has acquired HD ... discovery contract research organization (CRO). After completion of ... of WuXi, and will continue to focus on ... The acquisition will further strengthen WuXi,s R&D capability ...
(Date:1/19/2017)... 19, 2017  ArmaGen, Inc., today announced that ... as chief executive officer, as well as a ... to ArmaGen more than 17 years of executive ... of biotherapeutics and pharmaceuticals. "Mathias ... experience and skillset necessary to lead ArmaGen to ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the full spectrum of drug and device development, and Prism Clinical Research ... and clinicians, today announced Verified Clinical Trials (VCT) has been selected ...
Breaking Biology Technology:
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
Breaking Biology News(10 mins):